Changeflow GovPing Drug Safety Massachusetts Pharmacy Practice Definitions
Routine Guidance Added Final

Massachusetts Pharmacy Practice Definitions

Favicon for www.mass.gov MA Pharmacy Practice Resources & Guidance
Detected February 12th, 2026
Email

Summary

The Massachusetts Board of Registration in Pharmacy has issued a document defining key terms related to pharmacy practice. This guidance aims to clarify terminology for pharmacists and related entities operating within the state.

What changed

The Massachusetts Board of Registration in Pharmacy has released a document that provides definitions for terms pertinent to pharmacy practice. While the document itself does not specify an effective date, it serves as official guidance from the Board, clarifying the meaning of various terms that likely underpin existing regulations or will inform future regulatory interpretations.

This guidance is critical for pharmacists, pharmacy technicians, and potentially pharmaceutical manufacturers and distributors operating in Massachusetts. Compliance officers should review these definitions to ensure their organization's practices and documentation align with the Board's interpretations. While no immediate compliance deadline is stated, adherence to these definitions is expected to ensure proper interpretation and application of pharmacy laws and regulations within the state.

What to do next

  1. Review the definitions provided by the Massachusetts Board of Registration in Pharmacy.
  2. Ensure internal policies and procedures align with the defined terms.
  3. Update any relevant documentation or training materials to reflect the new definitions.

Source document (simplified)

PK ! / % [ContentTypes].xml ( N0EHC-j\X $@bړ/Ӗ=>"RRQ{c%3X@LڻCV^i7 Sx[Ab7ӓ@HRf$g`E*} G;V )B~)K0{j17X$)+n7u9bf}^筊&i/52\פ
$[53jų(,U񥏊+/疔6-FBR[lvn! }k}HG4"jhznn'XwB$\HODuDX7o @<l)OLA@"y߉oTP8nd lAO
TK6
PK ! N rels/.rels ( j0@ѽQN/c[ILj<]aGӓzsFu]U
^[x 1xpf#I)ʃY*Di")c$qU~31jH[{=E~
f?3-޲]Tꓸ2j),l0/%b
zʼn, /|f\Z?6!Y
o]A PK ! mG Y word/document.xml][o8~}Xu]SMta2U=ӀhYTS]%{%-%;cW\vl<$O6 ȔɘÕ~]zuoW$Nh@՜WӬ/0!@"[p5NUޘMh|;&p=V MԷH
1ץW99[5j3Ȍ͚72aߖ4XfI87I&eװṼA6(YQ80J&%0JMJ(mdSEBx9rB)G it#x2]<|8FkAaR&gA/W[yE~z+˟Y
Abf}K8)*˲rQ\I Ey@ɡ 2}IPEzESmLKUnd5U&XR2L@ĚsS06Y49n+UA'
K1p2%~ ^
O~
0/M(+AA,Q,ϐ&ۏiւ|Ra4zE4ZROi 3t|UFi
I̗%E?+
~SxuN@sQI?
Εz
]hO C߭5ڤ~E©cBA
޳TTd"[|?| `մc ;DohAL`'4!ښv>dIld66&WG+]>o!%
q%wU&x
7g0X}'0-sW!7 }ky,eNG[kG(ɍ-D!+PD?3>+iBP-%;h64
ݒWtLx,LCJHz'J,AD2/|- ߐhL
"W琔8-YbjѲ~r]3@2UV\sfȞcGjiZQ20Q苙=>ɩe'F$ Vtm7;ia֝
İrYA+ AE7MjC.4(:UcK=^|~x_e!!S9޼Y,uUVrOnu5)2(suvPqY
۵\{Q#ߢ[s*ދ{GGtYkyg \+ptX'Ęxl!W+ w74}`YfC=Uln'/cu3-ts+EUsOB(_dXm 2ghL+>+36쎣Unnʛ"[kG.6f%-Cu̐UZ{R0qLLx/3G5I*\{nRǫGQX̴W_zKFQ0'Xt4iB!_qi>}V~B=;]NJ!JWH"@O CkxU֕ӲkkPc^jݮԪMtA馬(u们yugOZ=RiտD)v+(Csi:MJ<wFlW aV,Y}N[W5#oq~{N1 I#ĵp:y~[={Y'H&Ӑ{4 <N؄,Z7r"i}!p*g=n-TIqk0yAcD舩YbH|~I^Crybe6
b2ǂg+1-up4+R>1}Ifk.@DBzρ/o٧kV5zE X{|D)ן H_ۋz&7P VЄx k3m'

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
Various State Agencies
Instrument
Guidance
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Healthcare providers Pharmaceutical companies
Geographic scope
State (Massachusetts)

Taxonomy

Primary area
Healthcare
Operational domain
Legal
Topics
Pharmaceuticals Professional Licensing

Get Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when MA Pharmacy Practice Resources & Guidance publishes new changes.

Free. Unsubscribe anytime.